CD44 in Bone Metastasis Development: A Key Player in the Fate Decisions of the Invading Cells?

被引:12
作者
Zer, Noy Shir [1 ]
Ben-Ghedalia-Peled, Noa [1 ]
Gheber, Levi A. [1 ]
Vago, Razi [1 ]
机构
[1] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol Eng, IL-8410501 Beer Sheva, Israel
关键词
CD44; Breast cancer; Prostate cancer; Metastasis; Bone metastasis; Osteomimicry; Dormancy; PROSTATE-CANCER CELLS; MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; IN-VITRO; HYALURONIC-ACID; OSTEOPONTIN; GROWTH; EXPRESSION; CLEAVAGE; ADHESION;
D O I
10.1007/s10585-023-10203-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A participant in key developmental processes, the adhesion glycoprotein CD44 is also expressed in several types of malignancies and can promote metastasis. In addition, the expression of CD44 isoforms in different types of cancer such as prostate and breast cancers may facilitate bone metastases by enhancing tumorigenicity, osteomimicry, cell migration, homing to bone, and anchorage within the bone specialized domains. Moreover, there is evidence that the CD44-ICD fragments in breast cancer cells may promote the cells' osteolytic nature. Yet the mechanisms by which CD44 and its downstream effectors promote the establishment of these cells within the bone are not fully elucidated. In this review, we summarize the current data on the roles played by CD44 in cancer progression and bone metastasis and the possible effects of its interaction with the different components of the bone marrow milieu.
引用
收藏
页码:125 / 135
页数:11
相关论文
共 105 条
[1]   Targeted Nanomedicine to Treat Bone Metastasis [J].
Adjei, Isaac M. ;
Temples, Madison N. ;
Brown, Shannon B. ;
Sharma, Blanka .
PHARMACEUTICS, 2018, 10 (04)
[2]   Interaction of CD44 with different forms of hyaluronic acid. Its role in adhesion and migration of tumor cells [J].
Alaniz, L ;
Cabrera, PV ;
Blanco, G ;
Ernst, G ;
Rimoldi, G ;
Alvarez, E ;
Hajos, SE .
CELL COMMUNICATION AND ADHESION, 2002, 9 (03) :117-130
[3]   Breast cancer stem cells: mechanobiology reveals highly invasive cancer cell subpopulations [J].
Alvarez-Elizondo, Martha B. ;
Weihs, Daphne .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (03)
[4]   Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity [J].
Ashkar, S ;
Weber, GF ;
Panoutsakopoulou, V ;
Sanchirico, ME ;
Jansson, M ;
Zawaideh, S ;
Rittling, SR ;
Denhardt, DT ;
Glimcher, MJ ;
Cantor, H .
SCIENCE, 2000, 287 (5454) :860-864
[5]   Hyaluronan and mesenchymal stem cells: from germ layer to cartilage and bone [J].
Astachov, Liliana ;
Vago, Razi ;
Aviv, Moran ;
Nevo, Zvi .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 :261-276
[6]   Mechanisms, Diagnosis and Treatment of Bone Metastases [J].
Ban, Jozef ;
Fock, Valerie ;
Aryee, Dave N. T. ;
Kovar, Heinrich .
CELLS, 2021, 10 (11)
[7]  
Barsky L, 2022, CLIN EXP METASTAS, P1
[8]   CD44 as a potential diagnostic tumor marker [J].
Basakran, Nawwaf S. .
SAUDI MEDICAL JOURNAL, 2015, 36 (03) :273-279
[9]   Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells [J].
Bellahcene, A. ;
Bachelier, R. ;
Detry, C. ;
Lidereau, R. ;
Clezardin, P. ;
Castronovo, V. .
BREAST CANCER RESEARCH AND TREATMENT, 2007, 101 (02) :135-148
[10]   CD44 ISOFORMS CONTAINING EXON V3 ARE RESPONSIBLE FOR THE PRESENTATION OF HEPARIN-BINDING GROWTH-FACTOR [J].
BENNETT, KL ;
JACKSON, DG ;
SIMON, JC ;
TANCZOS, E ;
PEACH, R ;
MODRELL, B ;
STAMENKOVIC, I ;
PLOWMAN, G ;
ARUFFO, A .
JOURNAL OF CELL BIOLOGY, 1995, 128 (04) :687-698